Sustained Improvements After Intervention to Prevent Contrast‐Associated Acute Kidney Injury: A Randomized Controlled Trial
Journal of the American Heart Association · 20.05.2025 · 14 (10)
DOI: 10.1161/jaha.124.038920 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 20.05.2025. Verfasst von Michael E Matheny und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics Vanderbilt University Medical Center Nashville TN USA. Hauptthemen laut MEDLINE: Acute Kidney Injury, Contrast Media, Cardiac Catheterization, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
In the IMPROVE AKI (A Cluster‐Randomized Trial of Team‐Based Coaching Interventions to Improve Acute Kidney Injury) trial, a combination of team‐based coaching and data‐driven surveillance dashboards reduced the odds of AKI following cardiac catheterization by 46%. The objective of this study was to determine if improvements in AKI outcomes would be sustained after completion of the active intervention. Methods and Results A 2×2 factorial cluster‐randomized trial with an 18‐month active intervention phase (October 2019–March 2021) and an 18‐month sustainability phase (April 2021–September 2022) conducted among cardiac catheterization laboratories in 20 Veterans Affairs sites. Interventions included team‐based coaching in a virtual learning collaborative or technical assistance, with and without access to an automated surveillance reporting dashboard. Data were collected on procedures involving adult patients undergoing diagnostic coronary angiography or percutaneous coronary interventions and not receiving chronic dialysis. The main outcome was AKI within 7 days of cardiac catheterization among all participants and those with preexisting chronic kidney disease. In addition, survey and focused interview data were collected to understand barriers and facilitators to sustaining AKI improvements. In this phase, 440 of 4160 patients experienced AKI, including 216 of 1260 patients with chronic kidney disease. Compared with technical assistance alone, we observed a reduction in AKI among virtual learning collaborative + automated surveillance reporting sites (adjusted odds ratio, 0.60 [95% CI, 0.42–0.86]). Sites had implemented standardized orders (11), oral and intravenous hydration standing orders (13), and contrast limiting protocols (10).
Conclusions
Team‐based coaching coupled with data‐driven surveillance dashboards reduced AKI by 40% during the 18 months after active participation in the trial. Process improvement education, care process standardization, and automated outcome feedback may be effective and durable methods for reducing AKI. Registration URL: https://clinicaltrials.gov/ ; Unique Identifier: NCT03556293.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Informatics Vanderbilt University Medical Center Nashville TN USA.
- Geriatric Research Education and Clinical Care Center Tennessee Valley Healthcare System VA Nashville TN USA.
- Department of Anthropology Dartmouth College Hanover NH USA.
- Department of Epidemiology Geisel School of Medicine at Dartmouth Hanover NH USA.
- The Dartmouth Institute for Health Policy and Clinical Practice Lebanon NH USA.
- University of Vermont Larner College of Medicine Burlington VT USA.
ORCID-Profile: Michael E Matheny, Sharon E Davis, Lisa Zubkoff, Dax M Westerman, Chad Dorn, Freneka F Minter, Hani Jneid, S Ahmed Athar, Saket Girotra, Calvin Leung, Thomas J Helton, Mary E Plomondon, Stephen W Waldo, Virginia McKay, A James O'Malley, Jeremiah R Brown
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Matheny, M. E., Carpenter-Song, E., Ricket, I. M., Solomon, R. J., Stabler, M. E., Davis, S. E., Zubkoff, L., Westerman, D. M., Dorn, C., Cox, K. C., Minter, F. F., Jneid, H., Currier, J. W., Athar, S. A., Girotra, S., Leung, C., Helton, T. J., Agarwal, A., Vidovich, M. I., …, & Brown, J. R. (2025). Sustained Improvements After Intervention to Prevent Contrast‐Associated Acute Kidney Injury: A Randomized Controlled Trial. Journal of the American Heart Association, 14(10). https://doi.org/10.1161/jaha.124.038920
Vancouver
Matheny ME, Carpenter-Song E, Ricket IM, Solomon RJ, Stabler ME, Davis SE, et al. Sustained Improvements After Intervention to Prevent Contrast‐Associated Acute Kidney Injury: A Randomized Controlled Trial. Journal of the American Heart Association. 2025;14(10). doi:10.1161/jaha.124.038920
BibTeX
@article{Matheny2025,
author = {Matheny, Michael E and Carpenter-Song, Elizabeth and Ricket, Iben M and Solomon, Richard J and Stabler, Meagan E and Davis, Sharon E and Zubkoff, Lisa and Westerman, Dax M and Dorn, Chad and Cox, Kevin C and Minter, Freneka F and Jneid, Hani and Currier, Jesse W and Athar, S Ahmed and Girotra, Saket and Leung, Calvin and Helton, Thomas J and Agarwal, Ajay and Vidovich, Mladen I and Plomondon, Mary E and Waldo, Stephen W and Aschbrenner, Kelly A and McKay, Virginia and O'Malley, A James and Brown, Jeremiah R},
title = {Sustained Improvements After Intervention to Prevent Contrast‐Associated Acute Kidney Injury: A Randomized Controlled Trial},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {10},
doi = {10.1161/jaha.124.038920}
}
EUVIMED